Willow vs Sprout Health: structured support vs fast-entry GLP-1
Quick verdict: Willow vs Sprout Health boils down to support versus speed. Willow emphasizes a telehealth-first oral GLP-1 program with progress tracking and follow-up consultations; Sprout Health emphasizes fast, low-friction entry and a $50 off first-month offer with clear outcome framing. Choose Willow for structured digital follow-up and Sprout Health for a fast start.
Explore Willow’s program and tracking
Willow vs Sprout Health: how they differ at a glance
This comparison focuses on five distinctive differences supported by the sources: care model and follow-up, onboarding speed, pricing and promotional framing, outcome messaging, and medication regulatory notes. The primary keyword Willow vs Sprout Health appears here to guide search intent and is used throughout.
1. Care model and ongoing support
Willow positions itself as a telehealth-first weight management program that pairs oral GLP-1 with progress tracking tools and follow-up consultations. The source frames Willow as structured around converting GLP-1 efficacy into longer-term outcomes through behavioral scaffolding and licensed telehealth teams.
Sprout Health is presented as a licensed telehealth GLP-1 platform that prioritizes speed and a straightforward online prescription review. Sprout emphasizes rapid approval and home delivery rather than an extended onboarding or tracking program.
2. Onboarding speed and friction
Sprout Health highlights a lightning-quick approval process and fast, hassle-free medication delivery, explicitly positioning itself for patients who want a fast entry to GLP-1 therapy. Willow’s messaging centers on structured workflows and follow-up; the source does not claim lightning-quick approval for Willow.
3. Pricing, promotions, and cost framing
Sprout Health advertises a promotion: Get $50 Off Your First Month, bringing the initial cost to $199, with standard ongoing pricing listed at $249/month after the discount. The source warns that the $249 ongoing rate is higher than several competitors.
Willow’s captured evidence lists a starting price of 299. The landing-page capture for Willow was not fully readable, so no additional verified pricing details, shipping, fees, membership, or cancellation terms were captured.
See Sprout Health pricing and offer
4. Outcome messaging and claims
Sprout Health frames outcomes around a 10–26% body weight reduction over 12 months, citing GLP-1 clinical outcome literature and stating individual results vary. The source notes Sprout does not offer a formal outcome guarantee despite the outcome-focused marketing.
Willow emphasizes turning GLP-1 efficacy into sustainable long-term outcomes through tracking and follow-up but does not publish a quantified outcome claim in the captured evidence.
5. Medication type and regulatory notes
Both providers note that treatment is available only when a licensed clinician determines it is medically appropriate. The sources state that when compounded medications are offered, they are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. Sprout’s captured evidence explicitly states it prescribes compounded semaglutide and that compounded medication is not a finished FDA-approved product. Willow’s evidence includes the regulatory note that compounded medications, when offered, are not FDA-approved.
Side-by-side comparison table
| Criteria | Willow | Sprout Health |
|---|---|---|
| Primary positioning | Telehealth-first with progress tracking and follow-up | Fast, low-friction GLP-1 entry with quick approval |
| Onboarding speed | Structured workflow and follow-up | Lightning-quick approval and fast home delivery |
| Starting price / promo | Starting price: 299 | $50 off first month; initial $199, $249/month ongoing |
| Outcome messaging | Focus on converting efficacy into sustainable outcomes via tracking | Frames 10–26% body weight loss over 12 months; no formal guarantee |
| Medication regulatory note | Compounded medications, when offered, are not FDA-approved | Compounded medication not FDA-approved; prescribes compounded semaglutide |
What the captured evidence does not show
The captured Willow landing page returned an error and did not provide readable details about shipping, fees, membership, cancellation, or expanded FAQs. Sprout Health’s landing-page capture did not produce readable landing-page evidence beyond the promotional and FAQ content cited. No independent verification of outcomes, long-term guarantees, or insurance billing details is supplied beyond the captured source statements.
Review Willow’s support features
How to choose between Willow and Sprout Health
Choose Willow if you prioritize a structured, telehealth-first program with progress tracking tools and follow-up consultations and are seeking behavioral support alongside medication. Choose Sprout Health if you prioritize rapid approval, a low-friction online start, and an initial promotional price point with clearly framed 10–26% outcome messaging. Both require a licensed clinician to determine medical appropriateness, and both note compounded medications are not FDA-approved when offered.